Literature DB >> 20379191

Salt sensitivity and circadian rhythm of blood pressure: the keys to connect CKD with cardiovascular events.

Genjiro Kimura1, Yasuaki Dohi, Michio Fukuda.   

Abstract

In healthy subjects, blood pressure (BP) drops by 10-20% during the night. Conversely, in patients with the salt-sensitive type of hypertension or chronic kidney disease, nighttime BP does not fall, resulting in an atypical pattern of circadian BP rhythm that does not dip. This pattern is referred to as the 'non-dipper' pattern. Loss of renal functional reserve, due to either reduced ultrafiltration capacity or enhanced tubular sodium reabsorption, induces the salt-sensitive type of hypertension. When salt intake is excessive in patients with salt-sensitive hypertension, the defect in sodium excretory capability becomes evident, resulting in elevated BP during the night. This nocturnal hypertension compensates for diminished natriuresis during the daytime and enhances pressure natriuresis during the night. Nocturnal hypertension and the non-dipper pattern of circadian BP rhythm cause cardiovascular events. When excess salt intake is loaded in patients who are in a salt-sensitive state, glomerular capillary pressure is also elevated, resulting in glomerular sclerosis and eventual renal failure. In this way, salt sensitivity and excess salt intake contribute to both cardiovascular and renal damage at the same time. We propose that salt sensitivity of BP and excess salt intake have important roles in the genesis of the cardiorenal connection. Salt sensitivity and circadian rhythm of BP are the keys to understanding the connections between cardiovascular and renal complications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20379191     DOI: 10.1038/hr.2010.47

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  40 in total

1.  To overcome two diseases with one pill.

Authors:  Masaki Mogi; Masatsugu Horiuchi
Journal:  Hypertens Res       Date:  2016-01-28       Impact factor: 3.872

Review 2.  Molecular bases of circadian rhythmicity in renal physiology and pathology.

Authors:  Olivier Bonny; Manlio Vinciguerra; Michelle L Gumz; Gianluigi Mazzoccoli
Journal:  Nephrol Dial Transplant       Date:  2013-07-30       Impact factor: 5.992

3.  A randomized trial of dietary sodium restriction in CKD.

Authors:  Emma J McMahon; Judith D Bauer; Carmel M Hawley; Nicole M Isbel; Michael Stowasser; David W Johnson; Katrina L Campbell
Journal:  J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 10.121

4.  Characterization of biological pathways associated with a 1.37 Mbp genomic region protective of hypertension in Dahl S rats.

Authors:  Allen W Cowley; Carol Moreno; Howard J Jacob; Christine B Peterson; Francesco C Stingo; Kwang Woo Ahn; Pengyuan Liu; Marina Vannucci; Purushottam W Laud; Prajwal Reddy; Jozef Lazar; Louise Evans; Chun Yang; Theresa Kurth; Mingyu Liang
Journal:  Physiol Genomics       Date:  2014-04-08       Impact factor: 3.107

5.  Renal Deletion of 12 kDa FK506-Binding Protein Attenuates Tacrolimus-Induced Hypertension.

Authors:  Rebecca A Lazelle; Belinda H McCully; Andrew S Terker; Nina Himmerkus; Katharina I Blankenstein; Kerim Mutig; Markus Bleich; Sebastian Bachmann; Chao-Ling Yang; David H Ellison
Journal:  J Am Soc Nephrol       Date:  2015-10-02       Impact factor: 10.121

6.  Renal Na-handling defect associated with PER1-dependent nondipping hypertension in male mice.

Authors:  Lauren G Douma; Meaghan R Holzworth; Kristen Solocinski; Sarah H Masten; Amber H Miller; Kit-Yan Cheng; I Jeanette Lynch; Brian D Cain; Charles S Wingo; Michelle L Gumz
Journal:  Am J Physiol Renal Physiol       Date:  2018-01-10

7.  Sodium restriction in heart failure: benefit or harm?

Authors:  Matthew C Konerman; Scott L Hummel
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-02

Review 8.  Circadian rhythm of blood pressure and the renin-angiotensin system in the kidney.

Authors:  Naro Ohashi; Shinsuke Isobe; Sayaka Ishigaki; Hideo Yasuda
Journal:  Hypertens Res       Date:  2016-12-01       Impact factor: 3.872

Review 9.  The Sacubitril/Valsartan, a First-in-Class, Angiotensin Receptor Neprilysin Inhibitor (ARNI): Potential Uses in Hypertension, Heart Failure, and Beyond.

Authors:  Kazuomi Kario
Journal:  Curr Cardiol Rep       Date:  2018-01-27       Impact factor: 2.931

10.  Disturbed circadian rhythm of the intrarenal renin-angiotensin system: relevant to nocturnal hypertension and renal damage.

Authors:  Shinsuke Isobe; Naro Ohashi; Tomoyuki Fujikura; Takayuki Tsuji; Yukitoshi Sakao; Hideo Yasuda; Akihiko Kato; Hiroaki Miyajima; Yoshihide Fujigaki
Journal:  Clin Exp Nephrol       Date:  2014-04-12       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.